4.6 Review

Therapeutic Targeting of Connexin Channels: New Views and Challenges

期刊

TRENDS IN MOLECULAR MEDICINE
卷 24, 期 12, 页码 1036-1053

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2018.10.005

关键词

-

资金

  1. FWO-Vlaanderen [1506218N, 1507118N, G051918N]
  2. Ghent University [BOF 14-GOA-019, IOP 01/O3618]
  3. Fund for Scientific Research Flanders, Belgium [G.0A82.13N, G.0527.18N]
  4. Interuniversity Attraction Poles Program, Ghent University [Special Research Fund (BOF)] [P7/10]
  5. Geneeskundige Stichting Koningin Elisabeth [STI.DI2.2017.0004.01]
  6. Flemish grants (EOS MODEL-IDI consortium) [G.0C31.14N, G.0C37.14N, G.0E04.16N, G.0C76.18N, G.0B71.18N]
  7. Methusalem [BOF16/MET_V/007]
  8. 'Foundation against Cancer' [FAF-F/2016/865]
  9. VIB
  10. FWO [G.0A54.13N]
  11. Methusalem grants

向作者/读者索取更多资源

Connexins, in particular connexin 43 (Cx43), function as gap junction channels (GJCs) and hemichannels (HCs). Only recently, specific tools have been developed to study their pleiotropic functions. Based on various protein interaction sites, distinct connexin-mimetic peptides have been established that enable discrimination between the function of HCs and GJCs. Although the precise mechanism of action of most of these peptides is still a matter of debate, an increasing number of studies report on important effects of those compounds in disease models. In this review, we summarize the structure, life cycle, and the most important physiological and pathological functions of both connexin GJCs and HCs. We provide a critical overview on the use of connexin-targeting peptides, in particular targeting Cx43, with a special focus on the remaining questions and hurdles to be taken in the research field of connexin channels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据